Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (30.523)

11

Lanadelumab for the treatment of hereditary angioedema

enthalten in: Expert opinion on biological therapy | 2019

von Wu, M.

12

The safety of belimumab for the treatment of systemic lupus erythematosus

enthalten in: Expert opinion on drug safety | 2019

von Wise, L. | Stohl, W.

13

Embouchure Claudication : A Trumpeter's Unique Presentation of Giant Cell Arteritis

enthalten in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society | 2019

von Chenevey, R. | Afkhamnejad, E. | Martin, T.

14

Complete response with neoadjuvant avelumab in Merkel cell carcinoma - A case report

enthalten in: Oral oncology | 2019

von Abdallah, N. | Nagasaka, M. | Chowdhury, T. | +3

15

Ocular Co-Morbidities of Atopic Dermatitis. Part II : Ocular Disease Secondary to Treatments

enthalten in: American journal of clinical dermatology | 2019

von Beck, K. | Seitzman, G. | Yang, E. | +2

16

Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

enthalten in: Japanese journal of clinical oncology | 2019

von Iwata, H. | Inoue, K. | Kaneko, K. | +6

ErratumIn: Jpn J Clin Oncol. 2020 Feb 17;50(2):223. - PMID 31950142

17

Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe Psoriasis

enthalten in: Clinical pharmacology and therapeutics | 2019

von Bruin, G. | Hasselberg, A. | Koroleva, I. | +6

18

A New Era in the Treatment of Thyroid Eye Disease

enthalten in: American journal of ophthalmology | 2019

von Patel, A. | Yang, H. | Douglas, R.

19

Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma

enthalten in: Journal of comparative effectiveness research | 2019

von Sharma, R. | Koruth, R. | Kanters, S. | +2

20

Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran : a case report

enthalten in: Journal of medical case reports | 2019

von Ohtani, T. | Sintoku, R. | Yajima, T. | +1